PT  - JOURNAL ARTICLE
AU  - Pei, Sen
AU  - Yamana, Teresa K.
AU  - Kandula, Sasikiran
AU  - Galanti, Marta
AU  - Shaman, Jeffrey
TI  - Overall burden and characteristics of COVID-19 in the United States during 2020
AID  - 10.1101/2021.02.15.21251777
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.15.21251777
4099  - http://medrxiv.org/content/early/2021/02/17/2021.02.15.21251777.short
4100  - http://medrxiv.org/content/early/2021/02/17/2021.02.15.21251777.full
AB  - The COVID-19 pandemic disrupted health systems and economies throughout the world during 2020 and was particularly devastating for the United States. Many of epidemiological features that produced observed rates of morbidity and mortality have not been thoroughly assessed. Here we use a data-driven model-inference approach to simulate the pandemic at county-scale in the United States during 2020 and estimate critical, time-varying epidemiological properties underpinning the dynamics of the virus. The pandemic in the US during 2020 was characterized by an overall ascertainment rate of 21.6% (95% credible interval (CI):18.9 – 25.5%). Population susceptibility at year’s end was 68.8% (63.4 – 75.3%), indicating roughly one third of the US population had been infected. Community infectious rates, the percentage of people harboring a contagious infection, rose above 0.8% (0.6 – 1.0%) before the end of the year, and were as high as 2.4% in some major metropolitan areas. In contrast, the infection fatality rate fell to 0.3% by year’s end; however, community control of transmission, estimated from trends of the time-varying reproduction number, Rt, slackened during successive pandemic waves. In the coming months, as vaccines are distributed and administered and new more transmissible virus variants emerge and spread, greater use of non-pharmaceutical interventions will be needed.Competing Interest StatementJS and Columbia University disclose partial ownership of SK Analytics. JS discloses consulting for BNI.Funding Statementhis study was supported by funding from the National Science Foundation (DMS-2027369) and a gift from the Morris-Singer Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data inputs are publicly available de-identified aggregate data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel output and code are posted at https://github.com/SenPei-CU/COVID_US_2020